Skip to content

DR. V. Reenaers

Active Private limited companyfounded 2008active for 18 yearsFlinkstraat 34, 3512 HasseltKBO/BCE: BE 0898.247.714

Lifetime

18 annual accounts with figures on one time axis
peak of €63,295 in 2019
€60,683unchanged
lowest -€4,390 in 2014
€14,593▼ 16.8%
peak of €303,577 in 2025
€303,577▲ 5.0%
€10,186▼ 10.5%
peak of 0.6 FTE in 2018
-not published
Board1 name since 2008
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
The year was quiet, with no large shift from the year before.

Key points

from the 2025 annual accounts

Equity

€303,577 ▲ 5.0%

DR. V. Reenaers has made a profit without a break since 2016.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

The last five annual accounts were filed 24 to 31 days before the end of the period.

Position in the sector

96.8%

Higher solvency than 94% of companies in human health. Sector median 63.0% · 21,347 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 10,916 companies had the same profile as DR. V. Reenaers has now. Each dot stands for 28 companies, two years later.

95.1%
were still trading
4.1%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 10,916 companies, not a prediction for DR. V. Reenaers. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 27-05-2008
  • 536 sharesdeed of 03-03-2014
Board & ownership

Recent changes

resigns as director reappointed as director · Director discharge: · General meeting of 28-07-2023 · Gazette deed
Capital increase of €97,469.12 to €116,069.12 The capital rose from €18,600 to €116,069.12, with 536 new shares · Gazette deed
First establishment Flinkstraat 34, Hasselt
Incorporation published on 10-06-2008 · Gazette deed
All 29 events

Comparable companies

same main activity, similar in size and age
Company
DR. V. Reenaers Hasselt €313,763 €60,683 96.8% -
JOHAN VAES Halen €317,050 €56,209 75.3% -
Société Médicale Docteur Ariane Bertholet Mons €332,906 €58,064 90.8% -
WATTIEZ ANESTHESIE & REANIMATION Soignies €310,132 €64,349 83.5% -
DEN ELS Ranst €290,695 €64,419 -10.8% -
DOCARNO Molenbeek-Saint-Jean €344,476 €59,062 12.8% -
Dr. VAN AKEN DAVID Schoten €304,885 €55,167 81.2% -

These companies have the same main activity as DR. V. Reenaers: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €291,000 and €344,000, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 27-05-2008Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.171.980.4483512 Hasselt, since 01-07-2008
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €130,000estimated
€313,763▲ 4.5%
Employeeson 31-12-2025
1=
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on DR. V. Reenaers

DR. V. Reenaers files the micro format. That format states no turnover. The gross margin rose from €39,350 in 2008 to €60,683 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. V. Reenaers

What is the company number of DR. V. Reenaers?
The company number of DR. V. Reenaers is 0898.247.714. The VAT number is the same number with BE in front: BE 0898.247.714.
Where is DR. V. Reenaers based?
The registered office is at Flinkstraat 34, 3512 Hasselt.Company details
What does DR. V. Reenaers do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. V. Reenaers?
DR. V. Reenaers is a private limited company (BV).
When was DR. V. Reenaers founded?
DR. V. Reenaers was founded on 27-05-2008.
Is DR. V. Reenaers still active?
Yes, DR. V. Reenaers is an active enterprise in the KBO register.
How many employees does DR. V. Reenaers have?
DR. V. Reenaers had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DR. V. Reenaers?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €60,683 and 33 comparable companies (NACE 862). It probably lies between €100,000 and €170,000.
Is DR. V. Reenaers profitable?
In financial year 2025, DR. V. Reenaers made a profit of €14,593.
Where can I find the annual accounts of DR. V. Reenaers?
DR. V. Reenaers filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. V. Reenaers due?
DR. V. Reenaers must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.